Cargando…
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
Objective To prospectively validate the HERDOO2 rule (Hyperpigmentation, Edema, or Redness in either leg; D-dimer level ≥250 μg/L; Obesity with body mass index ≥30; or Older age, ≥65 years), which states that women with none or one of the criteria can safely discontinue anticoagulants after short te...
Autores principales: | Rodger, Marc A, Le Gal, Gregoire, Anderson, David R, Schmidt, Jeannot, Pernod, Gilles, Kahn, Susan R, Righini, Marc, Mismetti, Patrick, Kearon, Clive, Meyer, Guy, Elias, Antoine, Ramsay, Tim, Ortel, Thomas L, Huisman, Menno V, Kovacs,, Michael J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287588/ https://www.ncbi.nlm.nih.gov/pubmed/28314711 http://dx.doi.org/10.1136/bmj.j1065 |
Ejemplares similares
-
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022) -
Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018) -
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018) -
Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
por: Catella, Judith, et al.
Publicado: (2022) -
Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism
por: Khan, Faizan, et al.
Publicado: (2023)